Literature DB >> 20171502

Use of normal tissue complication probability models in the clinic.

Lawrence B Marks1, Ellen D Yorke, Andrew Jackson, Randall K Ten Haken, Louis S Constine, Avraham Eisbruch, Søren M Bentzen, Jiho Nam, Joseph O Deasy.   

Abstract

The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review summarizes the currently available three-dimensional dose/volume/outcome data to update and refine the normal tissue dose/volume tolerance guidelines provided by the classic Emami et al. paper published in 1991. A "clinician's view" on using the QUANTEC information in a responsible manner is presented along with a description of the most commonly used normal tissue complication probability (NTCP) models. A summary of organ-specific dose/volume/outcome data, based on the QUANTEC reviews, is included. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20171502      PMCID： PMC4041542          DOI： 10.1016/j.ijrobp.2009.07.1754

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  21 in total

1.  Fitting of normal tissue tolerance data to an analytic function.

Authors:  C Burman; G J Kutcher; B Emami; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

2.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

Authors:  G J Kutcher; C Burman; L Brewster; M Goitein; R Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

3.  Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.

Authors:  Issam El Naqa; Jeffrey Bradley; Angel I Blanco; Patricia E Lindsay; Milos Vicic; Andrew Hope; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

4.  Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture.

Authors:  A Niemierko; M Goitein
Journal:  Radiother Oncol       Date:  1991-03       Impact factor: 6.280

5.  A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities.

Authors:  M Langer; S S Morrill; R Lane
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-05-01       Impact factor: 7.038

6.  Physician/patient-driven risk assignment in radiation oncology: reality or fancy?

Authors:  H I Amols; M Zaider; M K Hayes; P B Schiff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-06-01       Impact factor: 7.038

7.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Authors:  M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

8.  Value of whole brain re-irradiation for brain metastases--single centre experience.

Authors:  E Sadikov; A Bezjak; Q-L Yi; W Wells; L Dawson; B-A Millar; N Laperriere
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-07-26       Impact factor: 4.126

9.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.

Authors:  John P Kirkpatrick; Jeffrey J Meyer; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

10.  Analysis of clinical complication data for radiation hepatitis using a parallel architecture model.

Authors:  A Jackson; R K Ten Haken; J M Robertson; M L Kessler; G J Kutcher; T S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-02-15       Impact factor: 7.038
View more
  405 in total

1.  Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.

Authors:  Sanath Kumar; Ali S Arbab; Rajan Jain; Jinkoo Kim; Ana C deCarvalho; Adarsh Shankar; Tom Mikkelsen; Stephen L Brown
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

2.  Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.

Authors:  S Chatterjee; N Willis; S M Locks; J H Mott; C G Kelly
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Prophylactic cranial irradiation: the state of the art and areas of uncertainty.

Authors:  S Vilar-González; J J Aristu-Mendioroz; A Pérez-Rozos
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

4.  Stereotactic radiation therapy for skull base recurrences: Is a salvage approach still possible?

Authors:  Marco Krengli; Giuseppina Apicella; Letizia Deantonio; Marina Paolini; Laura Masini
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-04

Review 5.  Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.

Authors:  Joshua D Palmer; Nicholas G Zaorsky; Matthew Witek; Bo Lu
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

6.  MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.

Authors:  Judit Boda-Heggemann; Ulrike Attenberger; Johannes Budjan; Anika Jahnke; Lennart Jahnke; Lena Vogel; Anna O Simeonova-Chergou; Carsten Herskind; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2016-07-08       Impact factor: 3.621

Review 7.  Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.

Authors:  Nicole C Schmitt; Brandi R Page
Journal:  Int J Audiol       Date:  2017-07-20       Impact factor: 2.117

Review 8.  [Current diagnostics and therapy recommendations for ocular basal cell carcinoma].

Authors:  V Kakkassery; K U Loeffler; M Sand; K R Koch; A M Lentzsch; A C Nick; I A Adamietz; L M Heindl
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

9.  Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.

Authors:  Samhita Chakraborty; Monica M Morris; Todd W Bauer; Reid B Adams; Edward B Stelow; Gina Petroni; Hanna K Sanoff
Journal:  Gastrointest Cancer Res       Date:  2014-01

10.  Hepatotoxicity after liver irradiation in children and adolescents : results from the RiSK.

Authors:  Pascal Rösler; Hans Christiansen; Rolf-Dieter Kortmann; Carmen Martini; Christiane Matuschek; Frank Meyer; Christian Rübe; Thorsten Langer; Raphael Koch; Hans Theodor Eich; Normann Willich; Diana Steinmann
Journal:  Strahlenther Onkol       Date:  2014-12-09       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.